Publications by authors named "T Pascual"

Claim this Profile
A
Addition of ipatasertib to dual anti-HER2 maintenance therapy in HER2-positive metastatic breast tumors with PIK3CA mutations: the phase 1b SOLTI-1507 IPATHER trial.
Mafalda Oliveira, Eva Ciruelos, Guillermo Villacampa, Serafin Morales, Javier Salvador Bofill, Tomás Pascual

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palbociclib, trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer: randomised phase II, SOLTI-1303 PATRICIA trial.
Eva Ciruelos, Tomás Pascual, Guillermo Villacampa, Sonia Pernas, Rodrigo Sanchez Bayona

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into the Global Practice of Paediatric Renal Scintigraphy Studies.
Anita Brink, Zvi Bar-Sever, Pilar Orellana, Thoman Nb Pascual, Helen R Nadel

Semin Nucl Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine-based strategies after CDK4/6 inhibitors in biomarker-selected subgroup of hormone receptor positive advanced breast cancer: A systematic review and network meta-analysis.
Alicia Escudero, Meritxell Bellet, Cristina Saura, Anna Aguilera, Andri Papakonstantinou, Tomas Pascual

Cancer Treat Rev· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ki67 dynamic predicts endocrine sensitivity in estrogen receptor-positive/HER2-negative breast cancer patients undergoing preoperative endocrine therapy.
R Gómez-Bravo, B Walbaum, M Bergamino, O Martínez-Sáez, F Schettini, T Pascual

ESMO Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis